About Index Trending news
Lists
Pricing
Novo A/S

Novo A/S

Elsewhere

Alexa global traffic share

18 Jul 2017
$50,000,000
Venture capital (Series C)

Menlo Therapeutics Raises $50M in Series C Financing

FinSMEs
+1
11 Apr 2017
$40,000,000
Venture capital (Series A)

Cirius Therapeutics nets $40 mln

PE Hub
+1
29 Mar 2017
£1,010,000,000
Post-IPO equity

Proposed sale of stake in ConvaTec to Novo A/S

thepharmaletter
+2
02 Feb 2017
$30,000,000
Venture capital (Series D)

Tarveda Therapeutics Raises $30M in Series D Financing

FinSMEs
+1
05 Jan 2017
£23,000,000
Venture capital (Series B)

NeRRE Therapeutics picks up Series B funds

PE Hub
+2
15 Jun 2016
$33,000,000
Venture capital (Series B)

Rgenix Raises $33M, Preps Cancer Trial For Drug Shelved By GSK

Xconomy
+1
04 Apr 2016

Entasis Therapeutics Completes $50M Series B Financing

FinSMEs
+1
16 Mar 2016

Outpost Medicine raises $41 mln

PE Hub
+1
27 Jan 2016
$38,000,000
Venture capital (Series C)

Blend Rebrands as Tarveda, Raises $38M, and Spins Out Cancer Drug

Xconomy
+1
11 Jun 2015
17 Mar 2015
$27,343,269
Venture capital (Series E)
28 Apr 2014
04 Jun 2013
19 Dec 2012
$18,400,000
Venture capital (Series A)

Stevenage BioScience Catalyst | The Stevenage Voice - February 2013 |

stevenagecatalyst
+1
12 Apr 2012
$20,000,000
Venture capital
14 Oct 2010
$20,000,000
Venture capital (Series F)